The retina is the light-sensitive layer at the back of the eye, while the choroid supplies blood and nutrients to support retinal function. In dogs affected by CEA, these structures do not develop normally. This can lead to a range of abnormalities, including choroidal hypoplasia (underdevelopment of the choroid), retinal folds, colobomas (defects in eye structure), and in severe cases, retinal detachment.

The severity of Collie Eye Anomaly can vary significantly, even within the same litter. Some dogs may have very mild changes that do not affect vision, while others may experience significant structural abnormalities leading to partial or complete vision loss. Importantly, the condition is non-progressive in most cases, meaning the abnormalities are typically present at birth and do not worsen significantly over time, although complications like retinal detachment can cause further vision problems.

Clinical signs of CEA may not always be obvious, especially in mild cases. Many affected dogs appear visually normal and are only diagnosed through a detailed veterinary eye examination. In more severe cases, signs may include reduced vision, difficulty navigating in low light, or behavioral changes related to vision impairment.

The diagnosis of CEA is primarily made through a comprehensive ophthalmic examination performed by a veterinary ophthalmologist. This includes the use of a slit-lamp biomicroscope and indirect ophthalmoscope to examine the internal structures of the eye in detail. In young puppies, diagnosis can sometimes be more challenging because certain features, such as pigmentation changes, may evolve with age.

In addition to clinical eye examination, DNA testing for the NHEJ1 gene mutation is widely used to identify dogs carrying the genetic form of CEA. This allows breeders to determine whether a dog is clear, a carrier, or affected, even before visible eye changes can be detected.

Results are generally reported as:

  • Clear (Normal): No mutation detected and no signs of CEA on eye examination.
  • Carrier: One copy of the mutation; usually no clinical signs but can pass the gene to offspring.
  • Affected: Two copies of the mutation and/or visible ocular abnormalities consistent with CEA.

Collie Eye Anomaly is especially important in herding and related breeds, where the mutation is more common. Genetic screening and routine eye examinations are both strongly recommended before breeding to reduce the risk of passing on the condition to future generations.

For dog owners, early detection of CEA helps ensure proper monitoring of vision and prevents complications from unnoticed structural defects. While there is no cure for congenital abnormalities, many dogs with mild forms of CEA live normal lives with little or no impact on vision. In more severe cases, veterinary care and environmental adjustments can help maintain safety and quality of life.

The Collie Eye Anomaly (CEA) Health Test is a vital genetic and ophthalmic screening tool that supports early detection of inherited eye disease, improves breeding decisions, and helps preserve long-term vision health in dogs.